Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Interventional × Endocrine × Clear all

Phase

Status

Sponsor Class

OTHER 727 INDUSTRY 226 NIH 87 OTHER_GOV 17 NETWORK 14 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 67 Breast 43 Thoracic 25 Head & Neck 14 Lymphoid 12 Other hematologic neoplasm 6 CNS 6 Gynecologic 4 Sarcoma 3 Dermatologic 3 Other solid neoplasm 2 Genitourinary 2 Tumor-Agnostic 1 Other neoplasm 1 NET 1 Myeloid 1 Endocrine 1

Conditions

Extrapancreatic Neuroendocrine Tumor 1

Interventions

Thalidomide 1 Temozolomide 1 Tegafur 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03204032 2017-06-29

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor

ChineseAMS

Phase 2 Unknown

EndocrineGastrointestinalNET

Extrapancreatic Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡